IDEXX Laboratories stock rallies and outperforms competitors
Updated
Updated · MarketWatch · Apr 30
IDEXX Laboratories stock rallies and outperforms competitors
10 articles · Updated · MarketWatch · Apr 30
Shares rose 1.29% to $560.80 on Thursday, beating gains by Johnson & Johnson and Boston Scientific but trailing Medtronic in a broadly stronger US market.
The advance ended a two-day losing streak as the S&P 500 climbed 1.02% to 7,209.01 and the Dow Jones Industrial Average gained 1.62% to 49,652.14.
IDEXX still closed 27.17% below its 52-week high of $769.98 reached on 26 November, while trading volume of 708,407 topped its 50-day average of 519,954.
With a looming vet shortage, can IDEXX's high-tech diagnostics justify its premium stock price against industry headwinds?
IDEXX's forecast relies on its new AI tools, but can vets afford them amid rising operational costs and staff shortages?
As a new CEO prepares to take over, what is the plan to overcome the critical shortage of veterinarians?